Patient Journey COE (Expert Voice)

The RESECT Study: Improving Quality in TURBT Surgery - Veeru Kasivisvanathan

Details
Ashish Kamat is joined by Veeru Kasivisvanathan, Kevin Gallagher, and Nikita Bhatt — members of the global research group British Urology Researchers in Surgical Training (BURST) — discussing the global RESECT study. Transurethral REsection and Single instillation intravesical chemotherapy Evaluation in bladder Cancer Treatment (RESECT) Improving quality in TURBT surgery. The RESECT study investig...

The Relationship Between Surgeon Age and Post-Operative Outcomes - Raj Satkunasivam, Zachary Klaassen, Christopher Wallis

Details
In this Journal Club, Zachary Klaassen discusses a study on surgeon age with Raj Satkunasivam and Chris Wallis each an author on the paper titled, "Relationship Between Surgeon Age and Postoperative Outcomes, A Population-Based Cohort Study,” published in the Canadian Medical Association Journal. The surgical workforce, especially for urologists, is aging. This study aimed to determine whether pos...

Improving Research and Clinical Care, Bladder Cancer in Women - Jean Hoffman-Censits

Details
Medical Oncologist and co-leader of the Women's Bladder Cancer Program at John Hopkins, Jean Hoffman-Censits joins Alicia Morgans to speak about bladder cancer in women and the initiatives and importance of the Women's Bladder Cancer Program. In many cases, there are significant delays in diagnosing bladder cancer in women. Dr. Hoffman-Censits discusses the continuous narrative of the delay in dia...

The Impact of Nutrition, Diet and Lifestyle on Solitary Kidney Function - Kamyar Kalantar-Zadeh

Details
Jamie Landman and Monty Pal are joined by a multidisciplinary panel of experts to discuss the correlation between diet, nutrition, and lifestyle on solitary kidney function and cardiovascular health. Biographies: Kamyar Kalantar-Zadeh, MD, MPH, Ph.D., Chief and Professor, Department of Medicine’s Division of Nephrology & Hypertension, UC Irvine Connie Rhee, MD, Assistant Professor, Division of Nep...

In Pursuit of Patient-Centered Care - Karen Knudsen

Details
Karen Knudsen joins Alicia Morgans to discuss the motivation, vision, and drivers behind this year's GU ASCO 2020 meeting "in pursuit of patient-centered care". Along with other planning committee organization, Karen Knudsen was responsible for and played a key role in the formulation and direction of this year's meeting. She highlights the multidisciplinary considerations and new advancements the...

Advancing Prostate Cancer Research - The Prostate Cancer Clinical Trials Consortium (PCCTC) - Sarah Wise

Details
Sarah Wise, the Director of Research Operations at the Prostate Cancer Clinical Trials Consortium (PCCTC) sits down with Alicia Morgans to talk about the PCCTC, what the goals of the organization are, the benefit of the organization to patients, and how physicians, clinicians, and researchers can support what they are trying to do. The Prostate Cancer Clinical Trials Consortium (PCCTC) was initiat...

Patient-reported Outcomes from TITAN: Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer - Neeraj Agarwal

Details
In this conversation, Neeraj Agarwal joins Petros Grivas to discuss the Patient-Reported Outcomes (PRO) data from the TITAN study, Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer. This data was presented at ESMO 2019. The Food and Drug Administration approved apalutamide (ERLEADA, Janssen Biotech, Inc) for patients with metastatic hormone-sensitive prostate cancer. (mHSPC) in Sept...

Clinical Trials: Another Treatment Option for Patients - Tom Farrington

Details
Tom Farrington and Alicia Morgans discuss how to engage best with patients about clinical trials and clinical care. Tom emphasizes that patients are simply not aware of clinical trials that are available and that these trials present " another treatment option ". Clinical trials that offer randomization to the standard of care or the standard of care plus the additional treatment option being eval...

Immunotherapy Across Genitourinary Malignancies - James Gulley

Details
In this interview, James Gulley recaps the Keynote Lecture he gave at the GU ASCO 2019 annual symposium discussing immunotherapy across genitourinary malignancies and the different advancements in prostate, kidney and bladder cancer. Biographies: James L. Gulley, MD, PhD, Chief Genitourinary Malignancies, Director, Clinical Trials Group and of the Medical Oncology Service, Office of the Clinical D...
email news signup